Article: article from journal or magazin.
Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs.
Publication types: Journal Article
The choice of design between individual randomisation, cluster or pseudo-cluster randomisation is often made difficult. Clear methodological guidelines have been given for trials in general practice, but not for vaccine trials. This article proposes a decisional flow-chart to choose the most adapted design for evaluating the effectiveness of a vaccine in large-scale studies. Six criteria have been identified: importance of herd immunity or herd protection, ability to delimit epidemiological units, homogeneity of transmission probability across sub-populations, population's acceptability of randomisation, availability of logistical resources, and estimated sample size. This easy to use decisional method could help sponsors, trial steering committees and ethical committees adopt the most suitable design.
Clinical Trials, Phase III as Topic/methods, Clinical Trials, Phase IV as Topic/methods, Cluster Analysis, Disease Transmission, Infectious, Epidemiology, Humans, Immunity, Herd, Patient Selection, Randomized Controlled Trials as Topic/methods, Research Design, Sample Size, Vaccines
Web of science
Last modification date